Prophylactic Management of Women With Bipolar Disorder During Pregnancy and the Perinatal Period
暂无分享,去创建一个
Verinder Sharma | P. Boyce | A. Viguera | F. Uguz | A. Koukopoulos | C. Clark | M. Galbally | W. Marsh | A. Stevens
[1] S. Hernández-Díaz,et al. Reproductive Safety of Lurasidone and Quetiapine: Update from the National Pregnancy Registry for Psychiatric Medications. , 2023, Journal of women's health.
[2] O. Howes,et al. Time to re-evaluate the risks and benefits of valproate and a call for action , 2022, The British Journal of Psychiatry.
[3] E. Vieta,et al. Obstetric outcomes regarding the use of lithium in pregnant women with bipolar disorders: a prospective cohort study , 2022, Archives of Women's Mental Health.
[4] Stuart J. Watson,et al. Long-acting injectable antipsychotic treatment during pregnancy: Outcomes for women at a tertiary maternity hospital , 2022, Psychiatry Research.
[5] C. McDougle,et al. Association of Antipsychotic Drug Exposure in Pregnancy With Risk of Neurodevelopmental Disorders: A National Birth Cohort Study. , 2022, JAMA internal medicine.
[6] L. Forsberg,et al. Antipsychotic Use During Pregnancy and Risk for Gestational Diabetes: A National Register-Based Cohort Study in Sweden , 2022, CNS Drugs.
[7] C. van Kesteren,et al. Clozapine Treatment During Pregnancy and the Postpartum Period: A Systematic Literature Review. , 2021, The Journal of clinical psychiatry.
[8] A. Wikström,et al. Maternal lithium use and the risk of adverse pregnancy and neonatal outcomes: a Swedish population-based cohort study , 2021, BMC Medicine.
[9] M. Gissler,et al. Antipsychotic use in pregnancy and risk of attention/deficit-hyperactivity disorder and autism spectrum disorder: a Nordic cohort study , 2021, Evidence-Based Mental Health.
[10] Sabine J. Roza,et al. The effect of prenatal lithium exposure on the neuropsychological development of the child , 2021, Bipolar disorders.
[11] Kenneth K C Man,et al. Association Between Prenatal Exposure to Antipsychotics and Attention-Deficit/Hyperactivity Disorder, Autism Spectrum Disorder, Preterm Birth, and Small for Gestational Age , 2021, JAMA internal medicine.
[12] R. Ophoff,et al. Bipolar episodes after reproductive events in women with bipolar I disorder, A study of 919 pregnancies. , 2021, Journal of affective disorders.
[13] S. Hernández-Díaz,et al. Reproductive Safety of Second-Generation Antipsychotics: Updated Data From the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics. , 2021, The Journal of clinical psychiatry.
[14] Rachel Vanderkruik,et al. Breastfeeding practices among women taking second-generation antipsychotics: findings from the National Pregnancy Registry for Atypical Antipsychotics , 2021, Archives of Women's Mental Health.
[15] N. Craddock,et al. Mood episodes in pregnancy and risk of postpartum recurrence in bipolar disorder: The Bipolar Disorder Research Network Pregnancy Study. , 2021, Journal of affective disorders.
[16] M. Gissler,et al. Second-generation antipsychotic use during pregnancy and risk of congenital malformations , 2021, European Journal of Clinical Pharmacology.
[17] Sean T. Hwang,et al. Two-Year-Old Cognitive Outcomes in Children of Pregnant Women With Epilepsy in the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs Study. , 2021, JAMA neurology.
[18] D. Blumberger,et al. Repetitive transcranial magnetic stimulation (rTMS) in bipolar disorder: A systematic review , 2021, Bipolar disorders.
[19] F. Uguz,et al. Olanzapine and quetiapine in the prevention of a new mood episode in women with bipolar disorder during the postpartum period: a retrospective cohort study , 2021, Revista brasileira de psiquiatria.
[20] Kenneth K C Man,et al. Prenatal exposure to antipsychotic agents and the risk of congenital malformations in children: A systematic review and meta‐analysis , 2021, British journal of clinical pharmacology.
[21] A. Komaroff. Aripiprazole and lactation failure: The importance of shared decision making. A case report , 2021, Case reports in women's health.
[22] S. Hernández-Díaz,et al. Reproductive safety of aripiprazole: data from the Massachusetts General Hospital National Pregnancy Registry for Atypical Antipsychotics , 2021, Archives of Women's Mental Health.
[23] Y. Kaplan,et al. Use of phenytoin, phenobarbital carbamazepine, levetiracetam lamotrigine and valproate in pregnancy and breastfeeding: risk of major malformations, dose-dependency, monotherapy vs polytherapy, pharmacokinetics and clinical implications. , 2021, Current neuropharmacology.
[24] E. A. Whitham,et al. Citalopram for Acute and Preventive Efficacy in Bipolar Depression (CAPE-BD): A Randomized, Double-Blind, Placebo-Controlled Trial. , 2021, The Journal of clinical psychiatry.
[25] A. Young,et al. Long‐term treatment of bipolar disorder type I: A systematic and critical review of clinical guidelines with derived practice algorithms , 2020, Bipolar disorders.
[26] R. Porter,et al. The 2020 Royal Australian and New Zealand College of psychiatrists clinical practice guidelines for mood disorders: Bipolar disorder summary , 2020, Bipolar disorders.
[27] Liang Zheng,et al. Dose Adjustment of Quetiapine and Aripiprazole for Pregnant Women Using Physiologically Based Pharmacokinetic Modeling and Simulation , 2020, Clinical Pharmacokinetics.
[28] K. Deligiannidis,et al. Long-Acting Injectable Antipsychotic Use During Pregnancy: A Brief Review and Concise Guide for Clinicians. , 2020, The Journal of clinical psychiatry.
[29] Kenneth K C Man,et al. Association between antipsychotic use in pregnancy and the risk of gestational diabetes: Population-based cohort studies from the United Kingdom and Hong Kong and an updated meta-analysis , 2020, Schizophrenia Research.
[30] A. Kyritsis,et al. Reproductive health in patients with epilepsy , 2020, Epilepsy & Behavior.
[31] S. Marwaha,et al. Repetitive Transcranial Magnetic Stimulation in the Treatment of Bipolar Disorder , 2020, Therapeutic advances in psychopharmacology.
[32] T. Ikuta,et al. Mood stabilizers and/or antipsychotics for bipolar disorder in the maintenance phase: a systematic review and network meta-analysis of randomized controlled trials , 2020, Molecular Psychiatry.
[33] J. Christensen,et al. Association of Prenatal Exposure to Valproate and Other Antiepileptic Drugs With Intellectual Disability and Delayed Childhood Milestones , 2020, JAMA network open.
[34] P. Lichtenstein,et al. Antiseizure medication use during pregnancy and risk of ASD and ADHD in children , 2020, Neurology.
[35] T. Furukawa,et al. Adjunctive Psychotherapy for Bipolar Disorder: A Systematic Review and Component Network Meta-analysis. , 2020, JAMA psychiatry.
[36] A. McGirr,et al. The efficacy of repetitive transcranial magnetic stimulation (rTMS) for bipolar depression: A systematic review and meta-analysis. , 2020, Journal of affective disorders.
[37] F. Uguz. Selective serotonin reuptake inhibitors and the risk of congenital anomalies: a systematic review of current meta-analyses , 2020, Expert opinion on drug safety.
[38] S. Ito,et al. Infant drug exposure via breast milk , 2020, British journal of clinical pharmacology.
[39] F. Uguz. Neonatal and Childhood Outcomes in Offspring of Pregnant Women Using Antidepressant Medications: A Critical Review of Current Meta‐Analyses , 2020, Journal of clinical pharmacology.
[40] J. Ungerer,et al. Lurasidone in lactation: A case study with laboratory and clinical outcomes , 2020, Australian and New Zealand journal of psychiatry (Print).
[41] V. Bergink,et al. Management of lithium dosing around delivery: An observational study , 2020, Bipolar disorders.
[42] R. Ophoff,et al. Lithium Use during Pregnancy and the Risk of Miscarriage , 2020, Journal of clinical medicine.
[43] F. Uguz. Pharmacological prevention of mood episodes in women with bipolar disorder during the perinatal period: A systematic review of current literature. , 2020, Asian journal of psychiatry.
[44] O. Spigset,et al. Excretion of antipsychotics into the amniotic fluid, umbilical cord blood, and breast milk: A systematic critical review and combined analysis. , 2020, Therapeutic drug monitoring.
[45] Verinder Sharma,et al. Managing bipolar disorder during pregnancy and the postpartum period: a critical review of current practice , 2020, Expert review of neurotherapeutics.
[46] G. Sani,et al. Perinatal Mixed Affective State: Wherefore Art Thou? , 2020, The Psychiatric clinics of North America.
[47] F. Oort,et al. Neurocognition after prenatal levetiracetam, lamotrigine, carbamazepine or valproate exposure , 2020, Journal of Neurology.
[48] V. Morgan,et al. The association between gestational diabetes mellitus, antipsychotics and severe mental illness in pregnancy: A multicentre study , 2020, The Australian & New Zealand journal of obstetrics & gynaecology.
[49] Kenneth K C Man,et al. The use of antipsychotic agents during pregnancy and the risk of gestational diabetes mellitus: a systematic review and meta-analysis , 2020, Psychological Medicine.
[50] K. Meador,et al. Antiepileptic Drug Exposure in Infants of Breastfeeding Mothers With Epilepsy. , 2019, JAMA neurology.
[51] H. Swartz,et al. The chronotherapeutic treatment of bipolar disorders: A systematic review and practice recommendations from the ISBD task force on chronotherapy and chronobiology , 2019, Bipolar disorders.
[52] H. Swartz,et al. Evidence-Based Psychotherapies for Bipolar Disorder. , 2019, Focus.
[53] C. Ernst,et al. Psychopharmacological Decision Making in Bipolar Disorder During Pregnancy and Lactation: A Case-by-Case Approach to Using Current Evidence. , 2019, Focus.
[54] S. Hernández-Díaz,et al. Anticonvulsant Mood Stabilizer and Lithium Use and Risk of Adverse Pregnancy Outcomes. , 2019, The Journal of clinical psychiatry.
[55] P. Llorca,et al. Pharmacotherapy for the peripartum management of bipolar disorder , 2019, Expert opinion on pharmacotherapy.
[56] C. Tek,et al. Antipsychotic Exposure in Pregnancy and the Risk of Gestational Diabetes: A Systematic Review and Meta-analysis. , 2019, Schizophrenia bulletin.
[57] Shuo Zhang,et al. Pharmacokinetic changes and therapeutic drug monitoring of lamotrigine during pregnancy , 2019, Brain and behavior.
[58] M. Landén,et al. Psychoeducation for bipolar disorder and risk of recurrence and hospitalization – a within-individual analysis using registry data , 2019, Psychological Medicine.
[59] R. Kupka,et al. Risk of recurrence of mood disorders during pregnancy and the impact of medication: A systematic review. , 2019, Journal of affective disorders.
[60] D. Bogen,et al. Risk-Benefit assessment of infant exposure to lithium through breast milk: a systematic review of the literature , 2019, International review of psychiatry.
[61] F. Uguz. A New Safety Scoring System for the Use of Psychotropic Drugs During Lactation. , 2019, American journal of therapeutics.
[62] F. Uguz. Antipsychotic Use During Pregnancy and the Risk of Gestational Diabetes Mellitus: A Systematic Review , 2019, Journal of clinical psychopharmacology.
[63] A. Young,et al. Bipolar affective disorder and borderline personality disorder: Differentiation based on the history of early life stress and psychoneuroendocrine measures , 2019, Behavioural Brain Research.
[64] Stuart J. Watson,et al. Psychopharmacological prescribing practices in pregnancy for women with severe mental illness: A multicentre study , 2019, European Neuropsychopharmacology.
[65] D. Bogen,et al. Bipolar disorder and psychotropic medication: Impact on pregnancy and neonatal outcomes. , 2019, Journal of affective disorders.
[66] V. Bergink,et al. Lithium during pregnancy and after delivery: a review , 2018, International Journal of Bipolar Disorders.
[67] Stuart J. Watson,et al. Aripiprazole and pregnancy: A retrospective, multicentre study. , 2018, Journal of affective disorders.
[68] A. Young,et al. Mixed states in bipolar and major depressive disorders: systematic review and quality appraisal of guidelines , 2018, Acta psychiatrica Scandinavica.
[69] S. Hernández-Díaz,et al. Risk of Major Malformations in Infants Following First-Trimester Exposure to Quetiapine. , 2018, The American journal of psychiatry.
[70] Clare L. Taylor,et al. Maternal and infant outcomes associated with lithium use in pregnancy: an international collaborative meta-analysis of six cohort studies. , 2018, The lancet. Psychiatry.
[71] Sabine J. Roza,et al. Long-term neurodevelopmental consequences of intrauterine exposure to lithium and antipsychotics: a systematic review and meta-analysis , 2018, European Child & Adolescent Psychiatry.
[72] S. Kochen,et al. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry , 2018, The Lancet Neurology.
[73] S. Vigod,et al. Breastfeeding and lithium: is breast always best? , 2018, The lancet. Psychiatry.
[74] P. Videbech,et al. The Safety of Second-Generation Antipsychotics During Pregnancy: A Clinically Focused Review , 2018, CNS Drugs.
[75] Verinder Sharma,et al. Weighing the Risks: the Management of Bipolar Disorder During Pregnancy , 2018, Current Psychiatry Reports.
[76] Verinder Sharma,et al. Recurrence of bipolar disorder during pregnancy: a systematic review , 2018, Archives of Women's Mental Health.
[77] J. Calabrese,et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder , 2018, Bipolar disorders.
[78] G. Parker,et al. Is there consensus across international evidence-based guidelines for the psychotropic drug management of bipolar disorder during the perinatal period? , 2018, Journal of affective disorders.
[79] A. Fagiolini,et al. Aripiprazole use during pregnancy, peripartum and lactation. A systematic literature search and review to inform clinical practice. , 2018, Journal of affective disorders.
[80] H. Möller,et al. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Acute and long-term treatment of mixed states in bipolar disorder , 2018, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.
[81] Lingjiang Li,et al. Efficacy and safety of long-term antidepressant treatment for bipolar disorders - A meta-analysis of randomized controlled trials. , 2017, Journal of affective disorders.
[82] F. Uguz. Prophylactic use of olanzapine and quetiapine from pregnancy to the postpartum period in women with bipolar disorder: a case series , 2017, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[83] S. Wisniewski,et al. Adjunctive Bright Light Therapy for Bipolar Depression: A Randomized Double-Blind Placebo-Controlled Trial. , 2017, The American journal of psychiatry.
[84] M. Freeman,et al. Gestational Weight Gain and Pre-pregnancy Body Mass Index Associated With Second-Generation Antipsychotic Drug Use During Pregnancy. , 2017, Psychosomatics.
[85] S. Patten,et al. Second-Generation Antipsychotics and Metabolic Side Effects: A Systematic Review of Population-Based Studies , 2017, Drug Safety.
[86] S. Kushner,et al. Risk of postpartum episodes in women with bipolar disorder after lamotrigine or lithium use during pregnancy: A population-based cohort study. , 2017, Journal of affective disorders.
[87] A. Tricco,et al. Comparative safety of antiepileptic drugs for neurological development in children exposed during pregnancy and breast feeding: a systematic review and network meta-analysis , 2017, BMJ Open.
[88] S. Kushner,et al. Lithium dosing strategies during pregnancy and the postpartum period , 2017, British Journal of Psychiatry.
[89] S. Hernández-Díaz,et al. Lithium Use in Pregnancy and the Risk of Cardiac Malformations , 2017, The New England journal of medicine.
[90] A. Young,et al. British Association for Psychopharmacology consensus guidance on the use of psychotropic medication preconception, in pregnancy and postpartum 2017 , 2017, Journal of psychopharmacology.
[91] Verinder Sharma,et al. Peripartum management of bipolar disorder: what do the latest guidelines recommend? , 2017, Expert review of neurotherapeutics.
[92] R. V. Van Lieshout,et al. A review of the safety of clozapine during pregnancy and lactation , 2017, Archives of Women's Mental Health.
[93] C. Dintsios,et al. Letter to the editor of the Journal of Affective Disorders: Supporting the guideline's quest for real direct costs of depression care. , 2017, Journal of affective disorders.
[94] E. Larsen,et al. Pregnancy and bipolar disorder: the risk of recurrence when discontinuing treatment with mood stabilisers: a systematic review , 2016, Acta Neuropsychiatrica.
[95] A. Young,et al. The International College of Neuro-Psychopharmacology (CINP) Treatment Guidelines for Bipolar Disorder in Adults (CINP-BD-2017), Part 2: Review, Grading of the Evidence, and a Precise Algorithm , 2016, The international journal of neuropsychopharmacology.
[96] A. Serretti,et al. Bipolar II disorder as a risk factor for postpartum depression. , 2016, Journal of affective disorders.
[97] C. Begley,et al. Bipolar disorder in pregnancy and childbirth: a systematic review of outcomes , 2016, BMC Pregnancy and Childbirth.
[98] A. Carvalho,et al. Mood stabilizers and antipsychotics during breastfeeding: Focus on bipolar disorder , 2016, European Neuropsychopharmacology.
[99] S. Hernández-Díaz,et al. Antipsychotic Use in Pregnancy and the Risk for Congenital Malformations. , 2016, JAMA psychiatry.
[100] M. Loane,et al. The changing epidemiology of Ebstein’s anomaly and its relationship with maternal mental health conditions: a European registry-based study , 2016, Cardiology in the Young.
[101] F. Uguz. Second-Generation Antipsychotics During the Lactation Period: A Comparative Systematic Review on Infant Safety , 2016, Journal of clinical psychopharmacology.
[102] Verinder Sharma,et al. Mood stabilizers during breastfeeding: a systematic review of the recent literature , 2016, Bipolar disorders.
[103] F. Uguz. A pharmacological approach to panic disorder during pregnancy , 2016, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.
[104] C. Bowden,et al. Analysis of bipolar maintenance treatment with lithium versus olanzapine utilizing Multi‐state Outcome Analysis of Treatments (MOAT) , 2016, Bipolar disorders.
[105] Francesco Salvo,et al. Signal of Gastrointestinal Congenital Malformations with Antipsychotics After Minimising Competition Bias: A Disproportionality Analysis Using Data from Vigibase® , 2016, Drug Safety.
[106] C. Ernst,et al. Bipolar Disorder in Pregnancy and Postpartum: Principles of Management , 2016, Current Psychiatry Reports.
[107] T. Hale,et al. Drugs in Breast Milk. , 2015, Clinical obstetrics and gynecology.
[108] S. Wisniewski,et al. Maternal-Infant interaction in women with unipoloar and bipolar depression. , 2015, Applied nursing research : ANR.
[109] S. Kushner,et al. Risk of Postpartum Relapse in Bipolar Disorder and Postpartum Psychosis: A Systematic Review and Meta-Analysis. , 2015, The American journal of psychiatry.
[110] G. Koren,et al. Pregnancy Outcomes Following In Utero Exposure to Second-Generation Antipsychotics: A Systematic Review and Meta-Analysis , 2015, Journal of clinical psychopharmacology.
[111] J. Beyene,et al. Risks of congenital malformations in offspring exposed to valproic acid in utero: A systematic review and cumulative meta‐analysis , 2015, Clinical pharmacology and therapeutics.
[112] M. Bloch,et al. Obstetric and Neonatal Outcomes After Antipsychotic Medication Exposure in Pregnancy , 2015, Obstetrics and gynecology.
[113] M. Gissler,et al. Selective serotonin reuptake inhibitors and venlafaxine in early pregnancy and risk of birth defects: population based cohort study and sibling design , 2015, BMJ : British Medical Journal.
[114] J. Soares,et al. Bipolar disorder prevalence: a systematic review and meta-analysis of the literature. , 2015, Revista brasileira de psiquiatria.
[115] K. Meador,et al. IQ at 6 years after in utero exposure to antiepileptic drugs , 2015, Neurology.
[116] A. Marson,et al. Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child. , 2014, The Cochrane database of systematic reviews.
[117] H. Kapfhammer,et al. Clinical course of illness in women with early onset puerperal psychosis: a 12-year follow-up study. , 2014, The Journal of clinical psychiatry.
[118] A. Wieringa,et al. Concentrations of venlafaxine and its main metabolite O‐desmethylvenlafaxine during pregnancy , 2014, Journal of clinical pharmacy and therapeutics.
[119] A. Kilbourne,et al. Self-Management and Bipolar Disorder–A Clinician’s Guide to the Literature 2011-2014 , 2014, Current Psychiatry Reports.
[120] K. Meador,et al. Breastfeeding in children of women taking antiepileptic drugs: cognitive outcomes at age 6 years. , 2014, JAMA pediatrics.
[121] O. Spigset,et al. Transfer of aripiprazole to breast milk: a case report. , 2014, Journal of clinical psychopharmacology.
[122] M. Freeman,et al. Pharmacotherapy for Mood Disorders in Pregnancy: A Review of Pharmacokinetic Changes and Clinical Recommendations for Therapeutic Drug Monitoring , 2014, Journal of clinical psychopharmacology.
[123] S. Gentile. Risks of neurobehavioral teratogenicity associated with prenatal exposure to valproate monotherapy: a systematic review with regulatory repercussions , 2014, CNS Spectrums.
[124] L. Tata,et al. Sex prevalence of major congenital anomalies in the United Kingdom: A national population-based study and international comparison meta-analysis , 2014, Birth defects research. Part A, Clinical and molecular teratology.
[125] G. Maina,et al. Recurrence rates of bipolar disorder during the postpartum period: a study on 276 medication-free Italian women , 2014, Archives of Women's Mental Health.
[126] N. Delanty,et al. Malformation risks of antiepileptic drug monotherapies in pregnancy: updated results from the UK and Ireland Epilepsy and Pregnancy Registers , 2014, Journal of Neurology, Neurosurgery & Psychiatry.
[127] Verinder Sharma,et al. Pharmacotherapy of bipolar II disorder during and after pregnancy. , 2013, Current drug safety.
[128] A. Allignol,et al. Atypical Antipsychotic Drugs and Pregnancy Outcome: A Prospective, Cohort Study , 2013, Journal of clinical psychopharmacology.
[129] N. Craddock,et al. Perinatal episodes across the mood disorder spectrum. , 2013, JAMA psychiatry.
[130] L. Brandt,et al. Risks of adverse pregnancy and birth outcomes in women treated or not treated with mood stabilisers for bipolar disorder: population based cohort study , 2012, BMJ : British Medical Journal.
[131] Verinder Sharma,et al. Pregnancy and bipolar disorder: a systematic review. , 2012, The Journal of clinical psychiatry.
[132] S. Kushner,et al. Prevention of postpartum psychosis and mania in women at high risk. , 2012, The American journal of psychiatry.
[133] D. Bogen,et al. Three cases of lithium exposure and exclusive breastfeeding , 2012, Archives of Women's Mental Health.
[134] R. Baldessarini,et al. Episodes of mood disorders in 2,252 pregnancies and postpartum periods. , 2011, The American journal of psychiatry.
[135] C. Esmer,et al. Severe consequences of carbamazepine exposure in utero , 2011, BMJ Case Reports.
[136] R. Kessler,et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. , 2011, Archives of general psychiatry.
[137] K. Meador,et al. Effects of breastfeeding in children of women taking antiepileptic drugs , 2010, Neurology.
[138] D. Wildgruber,et al. Aripiprazole in pregnancy and lactation: a case report. , 2010, Journal of clinical psychopharmacology.
[139] Verinder Sharma,et al. Bipolar II postpartum depression: Detection, diagnosis, and treatment. , 2009, The American journal of psychiatry.
[140] W. Henrich,et al. Prospectively assessed changes in lamotrigine-concentration in women with epilepsy during pregnancy, lactation and the neonatal period , 2009, Epilepsy Research.
[141] T. Kircher,et al. Low concentration of ziprasidone in human milk: a case report. , 2009, The international journal of neuropsychopharmacology.
[142] Jonathan Green,et al. The impact of maternal psychopathology on child–mother attachment , 2009, Archives of Women's Mental Health.
[143] E. Holmes,et al. Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology , 2009, Journal of psychopharmacology.
[144] Melinda F. Davis,et al. Pharmacokinetics of Sertraline Across Pregnancy and Postpartum , 2008, Journal of clinical psychopharmacology.
[145] Mark Olfson,et al. Psychiatric disorders in pregnant and postpartum women in the United States. , 2008, Archives of general psychiatry.
[146] P. Pennell,et al. Lamotrigine in Breast Milk and Nursing Infants: Determination of Exposure , 2008, Pediatrics.
[147] N. Craddock,et al. Early postpartum symptoms in puerperal psychosis , 2008, BJOG : an international journal of obstetrics and gynaecology.
[148] R. Baldessarini,et al. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. , 2007, The American journal of psychiatry.
[149] R. Baldessarini,et al. Lithium in breast milk and nursing infants: clinical implications. , 2007, The American journal of psychiatry.
[150] K. Kendrick,et al. Quetiapine Augmentation in Lactation: A Series of Case Reports , 2006, Journal of clinical psychopharmacology.
[151] Verinder Sharma,et al. Olanzapine in the prevention of postpartum psychosis and mood episodes in bipolar disorder. , 2006, Bipolar disorders.
[152] A. Serretti,et al. Influence of postpartum onset on the course of mood disorders , 2006 .
[153] Olga V. Demler,et al. Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication. , 2005, Archives of general psychiatry.
[154] M. Clementi,et al. Safety of haloperidol and penfluridol in pregnancy: a multicenter, prospective, controlled study. , 2005, The Journal of clinical psychiatry.
[155] B. Hanusa,et al. Prevention of postpartum episodes in women with bipolar disorder , 2004, Biological Psychiatry.
[156] S. Vahip,et al. Risk Factors Associated with Childbearing-Related Episodes in Women with Bipolar Disorder , 2003, Psychopathology.
[157] G. Koren,et al. Monitoring lithium in breast milk: an individualized approach for breast-feeding mothers. , 2003 .
[158] P. Keck,et al. The impact of reproductive events on the course of bipolar disorder in women. , 2002, The Journal of clinical psychiatry.
[159] M. Alda,et al. Protective effect of pregnancy in women with lithium-responsive bipolar disorder. , 2000, Journal of affective disorders.
[160] T. Tomson,et al. Lamotrigine in Pregnancy: Pharmacokinetics During Delivery, in the Neonate, and During Lactation , 2000, Epilepsia.
[161] R. Baldessarini,et al. Risk of recurrence of bipolar disorder in pregnant and nonpregnant women after discontinuing lithium maintenance. , 2000, The American journal of psychiatry.
[162] G. Devore,et al. The aortic and pulmonary outflow tract screening examination in the human fetus , 1992, Journal of ultrasound in medicine : official journal of the American Institute of Ultrasound in Medicine.
[163] A. Young,et al. Lithium Exposure During Pregnancy and the Postpartum Period: A Systematic Review and Meta-Analysis of Safety and Efficacy Outcomes. , 2019, The American journal of psychiatry.
[164] E. Barzilay,et al. Pregnancy Outcomes Following In Utero Exposure to Lamotrigine: A Systematic Review and Meta-Analysis , 2017, CNS Drugs.
[165] B. Hanusa,et al. Onset timing, thoughts of self-harm, and diagnoses in postpartum women with screen-positive depression findings. , 2013, JAMA psychiatry.
[166] M. Loane,et al. The prevalence of congenital anomalies in Europe. , 2010, Advances in experimental medicine and biology.
[167] T. Einarson,et al. Long-Term Developmental Outcome of Children of Women with Epilepsy, Unexposed or Exposed Prenatally to Antiepileptic Drugs , 2010, Drug safety.
[168] G. Anderson. Pregnancy-Induced Changes in Pharmacokinetics , 2005, Clinical pharmacokinetics.